The purpose of this study is to compare the effectiveness of adding Seeking Safety to standard substance abuse treatment to adding a control condition: Women's Health Education to standard substance abuse treatment.

Condition	Treatment or Intervention	Phase
Substance-Related Disorders	Behavior: Behavior Therapy	Phase III

Further Study Details: 

Expected Total Enrollment:  460

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Female

Criteria

Inclusion Criteria

- Women with a diagnosis of substance abuse or dependence who also have either full or sub-threshold DSM-IV PTSD.

Exclusion Criteria:

- Women will be excluded from the study who have current psychotic disorders, or a history of active psychosis (past two months); women with a diagnosis of substance abuse or dependence who also have either full or sub-threshold DSM-IV PTSD; and women who have current psychotic disorders, or a history of active psychosis (past two months).

Aimee Campbell, M.S.      (212)523-5198    anoel_campbell@hotmail.com

Connecticut
      LMG Programs, Inc., Stamford,  Connecticut,  06901,  United States; Recruiting
Florida
      Gateway Community Services, Jacksonville,  Florida,  32224,  United States; Recruiting
      The Villiage, Miami,  Florida,  33137,  United States; Recruiting
New York
      Addiction Research & Treatment Corp.-MSUCAS, Brooklyn,  New York,  11238,  United States; Recruiting
      Addiction Research & Treatment Corp.-RISE, Brooklyn,  New York,  11238,  United States; Recruiting
Ohio
      Maryhaven, Inc., Columbus,  Ohio,  43207,  United States; Recruiting
South Carolina
      Charleston Center, Charleston,  South Carolina,  29403,  United States; Recruiting
Washington
      Residence XII, Kirkland,  Washington,  98034,  United States; Recruiting

Study chairs or principal investigators

Denise Hien, Ph.D.,  Principal Investigator,  New York State Psychiatric Institute   

Study ID Numbers:  NIDA-CTN-0015-1
Record last reviewed:  January 2005
Last Updated:  March 8, 2005
Record first received:  February 19, 2004
ClinicalTrials.gov Identifier:  NCT00078156
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08